Alliancebernstein L.P. 89bio, Inc. Transaction History

Alliancebernstein L.P.

$261 Billion
Q1 2025

A detailed history of Alliancebernstein L.P. transactions in 89bio, Inc. stock. As of the latest transaction made, Alliancebernstein L.P. holds 153,826 shares of ETNB stock, worth $1.38 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

153,826

Previous 1,042,136 85.24%

Holding current value

$1.38 Million

Previous $7.99 Million 86.01%

% of portfolio

0.0%

Previous 0.0%

14 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2025 May 15, 2025	SELL	$6.18 - $11.66 $5.49 Million - $10.4 Million	-888,310 Reduced 85.24%	153,826 $1.12 Million
Q4 2024 Feb 12, 2025	BUY	$7.03 - $10.05 $3.2 Million - $4.57 Million	455,074 Added 77.52%	1,042,136 $7.99 Million
Q3 2024 Nov 14, 2024	BUY	$7.36 - $9.66 $224,737 - $294,968	30,535 Added 5.49%	587,062 $4.34 Million
Q2 2024 Aug 14, 2024	BUY	$7.31 - $10.9 $2.38 Million - $3.55 Million	325,520 Added 140.91%	556,527 $4.46 Million
Q1 2024 May 14, 2024	SELL	$8.13 - $13.77 $552,693 - $936,112	-67,982 Reduced 22.74%	231,007 $2.69 Million
Q4 2023 Feb 14, 2024	SELL	$6.66 - $16.03 $297,602 - $716,300	-44,685 Reduced 13.0%	298,989 $3.34 Million
Q3 2023 Nov 14, 2023	BUY	$15.06 - $19.41 $1.85 Million - $2.39 Million	122,955 Added 55.71%	343,674 $5.31 Million
Q2 2023 Aug 15, 2023	BUY	$14.15 - $22.03 $3.12 Million - $4.86 Million	220,719 New	220,719 $4.18 Million
Q4 2022 Feb 14, 2023	BUY	$5.52 - $12.73 $722,441 - $1.67 Million	130,877 New	130,877 $1.67 Million
Q2 2022 Aug 15, 2022	SELL	$2.09 - $4.02 $26,543 - $51,053	-12,700 Closed	0 $0
Q1 2022 May 13, 2022	SELL	$3.45 - $14.99 $4,485 - $19,487	-1,300 Reduced 9.29%	12,700 $48,000
Q2 2021 Jul 30, 2021	BUY	$17.42 - $28.0 $38,324 - $61,600	2,200 Added 18.64%	14,000 $262,000
Q4 2020 Feb 08, 2021	BUY	$23.16 - $28.08 $41,688 - $50,544	1,800 Added 18.0%	11,800 $288,000
Q3 2020 Nov 12, 2020	BUY	$24.34 - $38.82 $243,400 - $388,200	10,000 New	10,000 $257,000

Others Institutions Holding ETNB

# of Institutions

208

Shares Held

158M

Call Options Held

366K

Put Options Held

944K

View Full List

About 89bio, Inc.

Ticker ETNB
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 46,484,500
Market Cap $417M
Description
89bio, Inc., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of therapies for the treatment of liver and cardio-metabolic diseases. Its lead product candidate is pegozafermin, a glycoPEGylated analog of fibroblast growth factor 21 for the treatment of nonalcoholic steatohepatitis. The company also int...

More about ETNB

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Alliancebernstein L.P., based on Form 13F filings with the SEC.

News

Stay updated on Alliancebernstein L.P. with notifications on news.

Account

Alliancebernstein L.P. 89bio, Inc. Transaction History